Baldo B
Arch Toxicol. 2024; 98(8):2409-2427.
PMID: 38743292
DOI: 10.1007/s00204-024-03765-8.
Traynor J, Roberts D, Ross S, Zeifman R, Choi-Kain L
Focus (Am Psychiatr Publ). 2023; 20(4):358-367.
PMID: 37200873
PMC: 10187385.
DOI: 10.1176/appi.focus.20220056.
Corkery J, Martinotti G, Schifano F
Curr Neuropharmacol. 2022; 21(11):2217-2226.
PMID: 36043796
PMC: 10556394.
DOI: 10.2174/1570159X20666220830110758.
Sessa B, Higbed L, Nutt D
Front Psychiatry. 2019; 10:138.
PMID: 30949077
PMC: 6435835.
DOI: 10.3389/fpsyt.2019.00138.
Obiechina N, Jayakumar A, Khan Y, Bass J
BMJ Case Rep. 2018; 2018.
PMID: 29627778
PMC: 5893955.
DOI: 10.1136/bcr-2017-223103.
The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant.
Sessa B
Psychopharmacology (Berl). 2017; 235(2):551-560.
PMID: 28831571
DOI: 10.1007/s00213-017-4713-7.
Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective.
Sessa B
Neurotherapeutics. 2017; 14(3):741-749.
PMID: 28477247
PMC: 5509627.
DOI: 10.1007/s13311-017-0531-1.
Psychostimulants and movement disorders.
Asser A, Taba P
Front Neurol. 2015; 6:75.
PMID: 25941511
PMC: 4403511.
DOI: 10.3389/fneur.2015.00075.
Substance-related health problems during rave parties in The Netherlands (1997-2008).
Krul J, Blankers M, Girbes A
PLoS One. 2012; 6(12):e29620.
PMID: 22216332
PMC: 3247283.
DOI: 10.1371/journal.pone.0029620.
Metabolites of MDMA induce oxidative stress and contractile dysfunction in adult rat left ventricular myocytes.
Shenouda S, Varner K, Carvalho F, Lucchesi P
Cardiovasc Toxicol. 2009; 9(1):30-8.
PMID: 19333788
PMC: 2859611.
DOI: 10.1007/s12012-009-9034-6.
Ecstasy produces left ventricular dysfunction and oxidative stress in rats.
Shenouda S, Lord K, McIlwain E, Lucchesi P, Varner K
Cardiovasc Res. 2008; 79(4):662-70.
PMID: 18495670
PMC: 2732062.
DOI: 10.1093/cvr/cvn129.
Clinical review: Major consequences of illicit drug consumption.
Devlin R, Henry J
Crit Care. 2008; 12(1):202.
PMID: 18279535
PMC: 2374627.
DOI: 10.1186/cc6166.
Ethanol-MDMA interactions in rats: the importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination.
Ben Hamida S, Plute E, Bach S, Lazarus C, Tracqui A, Kelche C
Psychopharmacology (Berl). 2007; 192(4):555-69.
PMID: 17345065
DOI: 10.1007/s00213-007-0752-9.
Substance abuse by children and young people.
McArdle P
Arch Dis Child. 2004; 89(8):701-4.
PMID: 15269062
PMC: 1720016.
DOI: 10.1136/adc.2003.040584.
A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities.
Schifano F
Psychopharmacology (Berl). 2003; 173(3-4):242-8.
PMID: 14673568
DOI: 10.1007/s00213-003-1730-5.
Dataset on deaths related to taking ecstasy looks incomplete.
Forrest A
BMJ. 2003; 326(7393):823.
PMID: 12689990
PMC: 1125729.
DOI: 10.1136/bmj.326.7393.823/b.
